Related Experiment Video
Updated: Jun 23, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Left ventricular thrombi after short-term high-dose anticoagulants in acute myocardial infarction
K A Johannessen1, J E Nordrehaug, G von der Lippe
1Medical Department, Diakonissehjemmet Hospital, Bergen, Norway.
Insights
Short-term anticoagulation after anterior myocardial infarction may lead to rapid left ventricular thrombi development. These thrombi can cause stroke, especially with persistent apical akinesis.
Area of Science:
- Cardiology
- Thrombosis Research
Background:
- Left ventricular thrombi (LVT) are a complication of anterior acute myocardial infarction (AMI).
- The impact of short-term, high-dose anticoagulation on LVT formation post-AMI requires investigation.
Purpose of the Study:
- To assess the effect of short-term, high-dose anticoagulation on LVT occurrence after first anterior wall AMI.
- To evaluate the relationship between LVT, subsequent embolic events, and echocardiographic findings.
Main Methods:
- A randomized study comparing placebo (n=21) and high-dose anticoagulation (n=21) during the first 10 days post-AMI.
- Cross-sectional echocardiography at 10 days, 1.3, and 6 months post-infarction.
- Analysis of LVT predictors (apical akinesis) and embolic complications (stroke).
Main Results:
- No LVT detected at 10 days in the anticoagulation group; 7/21 in placebo group.
- LVT developed in 6/21 patients in the anticoagulation group by 1 month.
- LVT resolved with warfarin but recurred in 5/12 patients after discontinuation.
- Apical akinesis predicted LVT (100% sensitivity, 72.2% specificity).
- Stroke occurred in 3/13 patients with LVT versus 0/11 without (P=0.025).
Conclusions:
- Short-term anticoagulation cessation in anterior AMI can lead to rapid LVT development.
- Persisting apical akinesis is a key predictor for LVT formation post-AMI.
- LVT pose an embolic risk, highlighting the need for vigilant monitoring and management.
Abstract:
To examine the effect of short-term, high-dose anticoagulation on the subsequent occurrence of left ventricular (LV) thrombi after a first anterior wall acute myocardial infarction (AMI), 21 patients received placebo and 21 high-dose anticoagulants during the first 10 days of the acute infarction. They were studied with cross-sectional echocardiography 10 days and 1.3 and 6 months post infarction. At 1 month, 6 of 7 thrombi present in the placebo group at 10 days were still visible. No thrombi were detected at 10 days in the anticoagulation group, but 6 patients had developed a LV thrombus at 1 month. These 12 patients with LV thrombi were subsequently treated with oral warfarin for 2 months, after which all thrombi had disappeared. Warfarin was then discontinued, and a thrombus had recurred in 5 patients after 6 months. Apical akinesis at 10 days was a predictor for thrombus with a sensitivity and specificity of 100% and 72.2%, respectively. Three of the 13 patients with LV thrombi suffered stroke in contrast to none without thrombi (P = 0.025). We conclude that after discontinuation of short-term high-dose anticoagulation therapy in anterior AMI, LV thrombi may develop rapidly and lead to embolic complications, particularly in patients with persisting apical akinesis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

